EGFRvIII-targeted vaccination therapy of malignant glioma. - Wikidata - wikimedia - TriplyDB

EGFRvIII-targeted vaccination therapy of malignant glioma.

EGFRvIII-targeted vaccination therapy of malignant glioma.

http://www.wikidata.org/entity/Q33758459

about

Are BiTEs the "missing link" in cancer therapy?Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma Immune factors and viral interactions in brain cancer etiology and outcomes, The 2016 Brain Tumor Epidemiology Consortium Meeting report Potential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastoma Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy.Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies.Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.Metabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma.Bispecific antibodies engage T cells for antitumor immunotherapy.Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model.Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.Proximity ligation assay evaluates IDH1R132H presentation in gliomas Personalized medicine for gliomas Immunotherapy for malignant glioma Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets.Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma.Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.Trial watch: Peptide vaccines in cancer therapy Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma.A novel bispecific antibody recruits T cells to eradicate tumors in the "immunologically privileged" central nervous system.Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma.Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody.EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced delivery.Therapeutic targeting of EGFR in malignant gliomas.Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.Brain cancer immunoediting: novel examples provided by immunotherapy of malignant gliomas.Immunotherapy for the treatment of glioblastoma.Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas.Current and future directions for Phase II trials in high-grade glioma.The molecular landscape of diffuse glioma and prospects for biomarker development.Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.Glioblastoma multiforme: State of the art and future therapeutics.Vaccine-based immunotherapy for glioblastoma.Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme.The future of glioblastoma therapy: synergism of standard of care and immunotherapy.Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target.Glioblastoma: molecular pathways, stem cells and therapeutic targets.

P2860

Q28083907-44B49C88-9282-498A-A82D-4302A65016F7 Q28087306-12164D49-C726-421F-97E0-B0286E394695 Q28393216-2879DC4E-805C-4FDD-9ED2-CF860BCF2E8D Q30652283-C044B2C0-B4EB-4EA4-B67D-269CEC5E506A Q30872679-88BA3D10-4794-4920-A4C3-E9985649537C Q33721106-1CCB2611-0DBE-4C6B-8A98-01426D956A91 Q33746514-63B91895-8B82-4A18-8D0F-91A2306B8952 Q33809397-7F4499AC-223D-4D23-BC4E-24066DBEF2EE Q33829265-FFA64DE0-1F5A-4B6A-AEAD-CD9EAF3F11B0 Q34174334-6EDA64CB-337A-4E94-98D0-534091FC3C18 Q34177244-28F958A4-3297-4215-B445-87AA5195C2F0 Q34181954-AE392E76-4537-4D09-B565-F557DAE5E0B9 Q34721530-39B5412D-5042-442E-81F5-94A084A4EF4E Q35056736-5F15BDEF-E0A2-4A55-9B19-A374744AD659 Q35114080-95086738-97AF-44E3-A3F9-A68837C5CB30 Q35114086-1A40CDDA-90F2-41C8-BBDC-7F286701DF78 Q35869744-A49F702E-1972-4C90-911F-757BDF50546D Q35914541-E4F3E57F-8B05-420A-9AEB-7DD617A709FC Q36280796-CDA9FAD3-F721-424A-8A84-8D6DFDEB15B2 Q36476100-822C0420-9AE3-4AA5-96BC-EB8D9CAE2072 Q36512160-E856ABED-B645-4249-9F96-19746624C700 Q36845815-CE5CDC41-92CF-4069-8345-64E97E8BC2A0 Q37154421-EEA0E0F3-0671-48A7-AB74-F0E3FBC90C55 Q37402375-237D37AF-5186-4853-9804-7889205231AA Q37598166-92799C06-7D09-4B7B-8929-094C348E0EA1 Q37686698-B6F348A7-9273-4D40-85DD-3DA328D257F1 Q37690755-88847145-C11B-4648-AB11-8CD6EE4E5CA0 Q37804933-B0AA85DA-0BAD-42D5-B332-BC5FC0B03579 Q37952245-DD2D24E3-B04F-4770-B619-DF3F917466F9 Q37980026-EFD7DFBB-B64A-4DF8-BD6F-D4F9AD58C2EF Q37981764-2981A74C-4178-46B9-AF74-76579BCFBA3C Q38094808-CAF1A7E8-28E8-4468-95D5-16C00423D36C Q38155656-47350ED9-6BAE-40C4-BB89-D2AEAACE6E9F Q38208182-3D68F9C6-E6B4-40FC-B505-2D61FE3E0D49 Q38225874-7040F58B-87D5-4566-8518-EB622D6CAB9D Q38233114-1CA5AC1A-011B-4C9F-888B-6C90A57D625C Q38245925-4ACE9656-D08A-4D9F-9AAF-4CDF7F817DCB Q38255481-C03B44B4-6C41-485F-A1F8-5EFE5DA31B6F Q38287518-02B884E0-84DA-49B7-AFEA-18201A21FDAC Q38393328-CFC0D6D0-77F8-44DB-8BF7-8FF3E7235AB0

P2860

EGFRvIII-targeted vaccination therapy of malignant glioma.

http://www.wikidata.org/entity/Q33758459

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

EGFRvIII-targeted vaccination therapy of malignant glioma.

@ast

EGFRvIII-targeted vaccination therapy of malignant glioma.

@en

type

label

EGFRvIII-targeted vaccination therapy of malignant glioma.

@ast

EGFRvIII-targeted vaccination therapy of malignant glioma.

@en

prefLabel

EGFRvIII-targeted vaccination therapy of malignant glioma.

@ast

EGFRvIII-targeted vaccination therapy of malignant glioma.

@en

P1433

Q33758459-BB74EE0D-BFC7-42AF-9EB0-04DE23B1673E

P1476

Q33758459-3C4BE05C-837B-4959-BE16-00309C5C2B21

P2093

Q33758459-0878B226-2A65-417E-A75E-8677E1DE4C8F

Q33758459-1CE0B295-99BB-455B-B42C-5C7373106BCC

Q33758459-23F9EBE9-BD08-491F-8E1E-F3B268F6C9E8

Q33758459-D6CA3F16-D371-484B-BB71-30BCAA570F07

Q33758459-E249E629-7ECA-4CD4-9BF7-60AEA3731883

P2860

Q33758459-014DE990-54E7-4EE0-B952-DC98496212C3

Q33758459-019FEFE4-07C7-4301-809B-353E13C8E530

Q33758459-01CDD360-1499-4204-B1B4-E4E6214AA6C6

Q33758459-02E2F9C8-9158-4BB8-A5E9-1D61B4A6CE3E

Q33758459-069C2266-86BA-4C92-9819-E8D3B6F5E158

Q33758459-06D37839-37FA-4DC1-AB84-22221D021033

Q33758459-0B2268E5-8F91-4276-903C-FC6D8871483C

Q33758459-0CEA2E72-379A-4E3C-87A9-37DF8C77231D

Q33758459-179F3FF1-0EAD-4619-8985-4B9DEED31E8D

Q33758459-1814F5F9-FE22-4AB9-AE17-81B62B727619

P304

Q33758459-6A3A8C59-33B7-4880-988D-2D1A21F9878A

P31

Q33758459-7F07D9ED-F18F-44D8-8F75-7786A2A07B6A

P356

Q33758459-4487371B-3D94-4B00-94CF-C9036F56FC12

P433

Q33758459-60BC8FDB-E1CB-4B1B-9182-A2EC9A4EC056

P478

Q33758459-5A44E1B7-546A-49E8-9720-9D04F9A5B6D0

P50

Q33758459-4FC4EEDD-1177-43C8-A8E6-DE23E9E6D7DF

Q33758459-8432624A-ECDF-40E0-866B-CD4533435021

P577

Q33758459-0F732550-E8CB-4531-AAA0-13B385AD7DA7

P5875

Q33758459-63CC85FC-CA15-43A9-A6FD-8BFCE0503095

P698

Q33758459-C00142ED-07D7-49C3-BC2F-B524DA77A025

P932

Q33758459-5157839B-A8D2-499E-921D-2B30309243DE

P356

J.1750-3639.2009.00318.X

P1433

Brain Pathology

P1476

EGFRvIII-targeted vaccination therapy of malignant glioma.

@en

P2093

Amy B Heimberger

http://www.w3.org/2001/XMLSchema#string

Bryan D Choi

http://www.w3.org/2001/XMLSchema#string

Duane A Mitchell

http://www.w3.org/2001/XMLSchema#string

Gary E Archer

http://www.w3.org/2001/XMLSchema#string

John H Sampson

http://www.w3.org/2001/XMLSchema#string

P2860

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

Cancer immunotherapy: moving beyond current vaccines

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Genetic instabilities in human cancers

Cancer. Addiction to oncogenes--the Achilles heal of cancer

Malignant astrocytic glioma: genetics, biology, and paths to treatment

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

P304

713-723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1750-3639.2009.00318.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Darell D. Bigner

Roger E McLendon

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26802347

http://www.w3.org/2001/XMLSchema#string

P698

19744042

http://www.w3.org/2001/XMLSchema#string

P932

2846812

http://www.w3.org/2001/XMLSchema#string